Abstract
The central role of G protein-coupled receptors (GPCRs) in most aspects of biological signal transduction has made them the object of extensive studies for a long period of time. These studies have revealed the key physiological roles of the many members of this family, and the manifold functions they have in the central nervous system (CNS) and the periphery (for recent reviews, see refs. [1,2]). Despite the abundance of information available in the literature, however, many of the fundamental questions regarding the molecular and structural requirements for GPCR function remain unanswered. A large number of reviews and compendia of results have been devoted to such fundamental elements in the biological mechanisms of GPCR (3–9). For this reason, we review here only some of the key aspects of recent progress in the development and application of approaches aiming to elucidate functional mechanisms of GPCRs in a detailed structural context. A central aim of our own collaborative studies of GPCRs is to develop such a coherent structural context (e.g., see [5,10–15]) that can serve in the interpretation, as well as the integration into a mechanistic understanding, of the abundant data about these systems. For this reason, we focus here specifically on the following three aspects of recent developments in the field: (1) the management of the copious data accumulated from structure-function studies, including genomic information; (2) some novel insights about intramolecular mechanisms triggering the activation of GPCRs; and (3) the recently characterized oligomerization of the receptors. The concluding Perspective section points to the integration of the mechanistic insights at the level of GPCR function with the growing understanding of signal-transduction pathways in the cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nature Rev. Mol. Cell Biol . 3, 639–650.
Rockman, H. A., Koch, W. J., and Lefkowitz, R. J. (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212.
Stenkamp, R. E., Teller, D. C., and Palczewski, K. (2002) Crystal structure of rhodopsin: a G protein-coupled receptor. Chem. BioChem . 3, 963–967.
Oussama, E. F. and Heinrich, B. (2002) G protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes. Biochem. J . 365, 329–336.
Visiers, I., Ballesteros, J. A., and Weinstein, H. (2002) Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol 343, 329–371.
Kroeze, W. K., Kristiansen, K., and Roth, B. L. (2002) Molecular biology of serotonin receptors structure and function at the molecular level. Curr. Top. Med. Chem . 2, 507–528.
Ballesteros, J. A., Shi, L., and Javitch, J. A. (2001) Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure—function analysis of rhodopsin-like receptors. Mol. Pharmacol . 60, 1–19.
Shi, L. and Javitch, J. A. (2002) The binding site of aminergic G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol . 42, 437–467.
Javitch, J. A., Ballesteros, J. A., Chen, J., Chiappa, V., and Simpson, M. M. (1999) Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. Biochemistry 38, 7961–7968.
Prioleau, C., Visiers, I., Ebersole, B. J., Weinstein, H., and Sealfon, S. (2002) Conserved helix7 tyrosine acts as a multistate conformational switch in the 5-HT2C receptor:Identification of a novel “locked-on” phenotype and double revertant mutations. J. Biol. Chem . 277, 36577–36584.
Ebersole, B. J., Visiers, I., Weinstein, H., and Sealfon, S. (2003) Molecular basis of partial agonism: orientation of indolamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. Mol. Pharmacol . 63, 36–43.
Huang, P., Li, J., Visiers, I., Weinstein, H., and Liu-Chen, L.-Y. (2001) Functional role of a conserved motif in TM6 of the rat m opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 40, 13501–13509.
Ballesteros, J. A., Kitanovic, S., Guarnieri, F., et al. (1998) Functional microdomains in G protein-coupled receptors: The conserved arginine cage motif in the gonadotropin-releasing hormone receptor. J. Biol. Chem . 273, 10445–10453.
Ballesteros, J. A. and Weinstein, H. (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366–428.
Gether, U., Lin, S., Ghanouni, P., Ballesteros, J. A., Weinstein, H., and Kobilka, B. K. (1997) Agonists induce conformational changes in transmembrane domains III and VI of the b2 adrenergic receptor. EMBO J. 16, 6737–6747.
Anastasiadis-Pool, A. and Schwalbe, H. (2002) Web sites about G protein-coupled receptors. ChemBioChem. 3, 1029–1030.
van Rhee, A. M. and Jacobson, K. A. (1996) Molecular architecture of G protein coupled receptors. Drug Dey. Res . 37, 1–38.
Kristiansen, K., Dahl, S. G., and Edvardsen, O. (1996) A database of mutants and effects of site-directed mutagenesis experiments on GPCRs. Prot. Struct. Func. Genet . 26, 81–94.
Beukers, M. W., Kristiansen, I., AP, I. J., and Edvardsen, I. (1999) TinyGRAP database: a bioinformatics tool to mine G protein-coupled receptor mutant data. Trends Pharmacol. Sci . 20, 475–477.
Campagne, F., Jestin, R., Reversat, J. L., Bernassau, J. M., and Maigret, B. (1999) Visualisation and integration of G protein-coupled receptor related information help the modelling: description and applications of the Viseur program. J. Comput, Aided Mol. Des . 13, 625–643.
Campagne, F. and Weinstein, H. (1999) Schematic representation of residue-based protein context-dependent data: an application to transmembrane proteins. J. Mol. Graph. Model 17, 207–213.
Konvicka, K., Campagne, F., and Weinstein, H. (2000) Interactive construction of residue-based diagrams of proteins: the RbDe web service. Prot. Eng . 13, 395–396.
Horn, F., Bywater, R., Krause, G., et al. (1998) The interaction of class B G protein-coupled receptors with their hormones. Recep. Channels 5, 305–314.
Bairoch, A. and Apweiler, R. (2000) The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 28, 45–48.
Cotton, R. G. and Horaitis, O. (2002) The HUGO Mutation Database Initiative. Human Genome Organization. Pharmacogen. J . 2, 16–19.
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., and Sirotkin, K. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311.
Small, K. M., Seman, C. A., Castator, A., Brown, K. M., and Liggett, S. B. (2002) False positive non-synonymous polymorphisms of G protein coupled receptor genes. FEBS Lett. 516, 253–256.
Visiers, I., Hassan, S. A., and Weinstein, H. (2001) Differences in conformational properties of the second intracellular loop (IL2) in 5HT(2C) receptors modified by RNA editing can account for G protein coupling efficiency. Prot. Eng . 14, 409–414.
Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., and Roth, B. L. (2002) Evidence for a model of agonist-induced activation of 5-HT2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem . 277, 11441–11449.
Fanelli, F., Menziani, C., Scheer, A., Cotecchia, S., and DeBenedetti, P. G. (1999) Theoretical study on receptor-G protein recognition: new insights into the mechanism of the albadrenergic receptor activation. Intl. J. Quant. Chem . 73, 71–83.
Fanelli, F. (2000) Theoretical study on mutation-induced activation of the luteinizing hormone receptor. J. Mol. Biol . 296, 1333–1351.
Huang, P., Visiers, I., Weinstein, H., and Liu-Chen, L.-Y. (2002) The local environment at the cytoplasmic end of TM6 of the m opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the m opioid receptor and reduces the constitutive activity of its Thr6.34(279)K mutant. Biochemistry 41, 11972–11980.
Jensen, A. D., Guarnieri, F., Rasmussen, S. G., Asmar, F., Ballesteros, J. A., and Gether, U. (2001) Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J. Biol. Chem . 276, 9279–9290.
Ghanouni, P., Gryszynski, Z., Steeinhuis, J. J., Lee, T. W., Farrens, D. L., Lakowitz, J. R., and Kobilka, B. K. (2001) Functionally different agonists induce distinct conformations in the G protein coupling domain of the 32 adrenergic receptor. J. Biol. Chem . 276, 24433–24436.
Ghanouni, P., Steenhuis, J. J., Farrens, D. L., and Kobilka, B. K. (2001) Agonist-induced conformational changes in the G protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl. Acad. Sci. USA 98, 5997–6002.
Chalmers, D. T. and Behan, D. P. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nat. Rev. Drug Dis . 1, 599–608.
Klabunde, T. and Hessler, G. (2002) Drug design strategies for targeting G protein-coupled receptors. ChemBioChem 3, 928–944.
Singh, R., Hurst, D. R, Barnett-Norris, J., Lynch, D. L., Reggio, P. H., and Guarnieri, F. (2002) Activation of the cannabinoid CB 1 receptor may involve a W6.48/F3.36 rotamer toggle switch. J. Peptide Res . 60, 357–370.
Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., and Javitch, J. A. (2002) beta2 Adrenergic receptor activation. J. Biol. Chem . 277, 40989–40996.
Sealfon, S. C., Chi, L., Ebersole, B. J., Rodic, V., Zhang, D., Ballesteros, J. A., and Weinstein, H. (1995) Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J. Biol. Chem . 270, 16683–16688.
Visiers, I., Ebersole, B. J., Dracheva, S., Ballesteros, J., Sealfon, S. C., and Weinstein, H. (2002) Structural motifs as functional microdomains in GPCRs: energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage. Intl. J. Quant. Chem . 88, 65–75.
Ballesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G., Shi, L., Gether, U., and Javitch, J. A. (2001) Activation of the beta 12 adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem . 276, 29171–29177.
Palczewski, K., Kumasaka, T., Hori, T., et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739–745.
Teller, D. C., Okada, T., Behnke, C. A., Palczewski, K., and Stenkamp, R. E. (2001) Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G protein-coupled receptors (GPCRs). Biochemistry 40, 7761–7772.
Angelova, K., Fanelli, F., and Puett, D. (2002) A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J. Biol. Chem . 277, 32202–32213.
Greasley, P. J., Fanelli, F., Scheer, A., Abuin, L., Nenniger-Tosato, M., DeBenedetti, P. G., and Cotecchia, S. (2001) Mutational and computational analysis of the alpha(1 b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J. Biol. Chem . 276, 46485–46495.
Greasley, P. J., Fanelli, F., Rossier, O., Abuin, L., and Cotecchia, S. (2002) Mutagenesis and modelling of the alpha(lb)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol . 61, 1025–1032.
Cotecchia, S., Rossier, O., Fanelli, F., Leonardi, A., and De Benedetti, P. G. (2000) The alpha la and alpha lb-adrenergic receptor subtypes: molecular mechanisms of receptor activation and of drug action. Pharm. Acta Heiv . 74, 173–179.
Zhou, W., Flanagan, C., Ballesteros, J. A., et al. (1994) A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol . 45, 165–170.
Xu, W., Ozdener, F., Li, J. G., Chen, C., de Riel, J. K., Weinstein, H., and Liu Chen, L.-Y. (1999) Functional role of the spatial proximity of Asp2.50(114) in TMH2 and Asn7.49(332) in TMH7 of the opioid receptor. FEBS Lett. 447, 318–324.
Sealfon, S. C., Chi, L., Ebersole, B. J., Rodic, V., Zhang, D., Ballesteros, J. A., and Weinstein, H. (1995) Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J. Biol. Chem . 270, 16683–16688.
Meng, E. C. and Boume, H. R. (2001) Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol. Sci . 22, 587–593.
Javitch, J. A., Ballesteros, J. A., Weinstein, H., and Chen, J. (1998) A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding site crevice. Biochemistry 37, 998–1006.
Krishna, A. G., Menon, S. T., Terry, T. J., and Sakmar, T. P. (2002) Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. Biochemistry 41, 8298–8309.
Choudhary, M. S., Craigo, S., and Roth, B. L. (1993) A single point mutation (Phe340 to Leu340) of a conserved phenylalanin abolishes 4-[125I]lodo-(2,5-dimethoxy) phenylisopropylamine and [3H]Mesulergine but not [3H]Ketanserin binding to 5-hydroxytryptamine2 receptors. Mol. Pharmacol . 43, 755–761.
Visiers, I., Ballesteros, J. A., and Weinstein, H. (2000) A spatially ordered sequence of intramolecular rearrangements observed from simulations of agonist-related activation of 5HT(2C) receptors. Biophys. J . 78, 394.
Lin, S. W. and Sakmar, T. R. (1996) Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. Biochemistry 35, 11149–11159.
Choudhary, M. S., Craigo, S., and Roth, B. L. (1992) Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1C serotonin receptors. Mol. Pharmacol . 42, 627–633.
Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., and Khorana, H. G. (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768–770.
Klein-Seetharaman, J. (2002) Dynamics in rhodopsin. ChemBioChem 3, 981–986.
Sheikh, S. R, Zvyaga, T. A., Lichtarge, O., Sakmar, T. R, and Bourne, H. R. (1996) Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383, 347–350.
Sansom, M. S. R. and Weinstein, H. (2000) Hinges, swivels and switches: the role of pro-lines in signalling via transmembrane alpha-helices. Trends Pharmacol. Sci . 21, 445–451.
Tieleman, D. R, Shrivastava, I. H., Ulmschneider, M. R., and Sansom, M. S. (2001) Proline-induced hinges in transmembrane helices: possible roles in ion channel gating. Proteins 44, 63–72.
Ballesteros, J. A. and Weinstein, H. (1992) The role of Pro/Hyp-kinks in determining the transmembrane helix length and gating mechanism of a Leu-zervamicin channel. Biophys. J . 62, 110–111.
Visiers, I., Braunheim, B. B., and Weinstein, H. (2000) Prokink: a protocol for numerical evaluation of helix distortions by proline. Prot. Eng . 13, 603–606.
Scheer, A., Costa, T., Fanelli, F., et al. (2000) Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(lb)-adrenergic receptor: effects on receptor isomerization and activation. Mol. Pharmacol . 57, 219–231.
Christopoulos, A. and Kenakin, T. (2002) G protein-coupled receptor allosterism and cornplexing. Pharmacol. Rev . 54, 323–374.
Brady, A. E. and Limbird, L. E. (2002) G protein coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal . 14, 297–309.
George, S. R., O’Dowd, B. F., and Lee, S. P. (2002) Oligomerization and its potential for drug discovery. Nat. Rev. Drug Disc . 1, 808–820.
Kenakin, T. (2002) Efficacy at G protein-coupled receptors. Nat. Rev. Drug Discov . 1, 103–110.
Hur, E. M. and Kim, K. T. (2002) G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell. Signal . 14, 397–405.
Angers, S., Salahpour, A., and Bouvier, M. (2002) Dimerization: an emerging concept for G protein coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol . 42, 409–435.
Levac, B. A., O’Dowd, B. F., and George, S. R. (2002) Oligomerization of opioid receptors: generation of novel signaling units. Curr. Opin. Pharmacol . 2, 76–81.
Lee, S. P., O’Dowd, B. F., Ng, G. Y., et al. (2000) Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol. Pharmacol . 58, 120–128.
Karpa, K. D., Lin, R., Kabbani, N., and Levenson, R. (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3–D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol . 58, 677–683.
Benkirane, M., Jin, D. Y., Chun, R. F., Koup, R. A., and Jeang, K. T. (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem . 272, 30603–30606.
Zhu, X. and Wess, J. (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37, 15773–15784.
Kuner, R., Kohr, G., Grunewald, S., Eisenhardt, G., Bach, A., and Kornau, H. C. (1999) Role of heteromer formation in GABAB receptor function. Science 283, 74–77.
Jones, K. A., Borowsky, B., Tamm, J. A., et al. (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396, 67 /1 679.
White, J. H., Wise, A., Main, M. J., et al. (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396, 679–682.
Kaupmann, K., Malitschek, B., Schuler, V., et al. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683–687.
Limbird, L. E., Meyts, P. D., and Lefkowitz, R. J. (1975) Beta-adrenergic receptors: evidence for negative cooperativity. Biochem. Biophys. Res. Commun . 64, 1160–1168.
Henis, Y. I. and Sokolovsky, M. (1983) Muscarinic antagonists induce different receptor conformations in rat adenohypophysis. Mol. Pharmacol . 24, 357–365.
Mattera, R., Pitts, B. J., Entman, M. L., and Birnbaumer, L. (1985) Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo-and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. J. Biol. Chem . 260, 7410–7421.
Wreggett, K. A. and Wells, J. W. (1995) Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem . 270, 22488–22499.
Gines, S., Hillion, J., Torvinen, M., et al. (2000) Dopamine D1 and adenosine Al receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA 97, 8606–8611.
Chazenbalk, G. D., Kakinuma, A., Jaume, J. C., McLachlan, S. M., and Rapoport, B. (1996) Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 137, 4586–4591.
Boyer, J. L., Martinez-Carcamo, M., Monroy-Sanchez, J. A., Posadas, C., and GarciaSainz, J. A. (1986) Guanine nucleotide-induced positive cooperativity in muscariniccholinergic antagonist binding. Biochem. Biophys. Res. Commun . 134, 172–177.
Potter, L. T., Ballesteros, L. A., Bichajian, L. H., Ferrendelli, C. A., Fisher, A., Hanchett, H. E., and Zhang, R. (1991) Evidence of paired M2 muscarinic receptors. Mol. Pharmacol . 39, 211–221.
Sinkins, W. G., Kandel, M., Kandel, S. I., Schunack, W., and Wells, J. W. (1993) G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]. Mol. Pharmacol . 43, 583–594.
Hirschberg, B. T. and Schimerlik, M. I. (1994) A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J. Biol. Chem . 269, 26127–26135.
Armstrong, D. and Strange, P. G. (2001) Dopamine d2 receptor dimer formation. evidence from ligand binding. J. Biol. Chem . 276, 22621–22629.
Pizard, A., Marchetti, J., Allegrini, J., Alhenc-Gelas, F., and Rajerison, R. M. (1998) Negative cooperativity in the human bradykinin B2 receptor. J. Biol. Chem . 273, 1309–1315.
Abd-Alla, S., Lother, H., and Quitterer, U. (2000) AT1-receptor heterodimers show enhanced G protein activation and altered receptor sequestration. Nature 407, 94–98.
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., and Patel, Y. C. (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288, 154–157.
Jordan, B. A. and Devi, L. A. (1999) G protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697–700.
George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., and O’Dowd, B. E (2000) Oligomerization of mu-and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem . 275, 26128–26135.
Mellado, M., Rodriguez-Frade, J. M., Vila-Coro, A. J., Fernandez, S., Martin De Ana, A., Jones, D. R., et al. (2001) Chemokine receptor homo-or heterodimerization activates distinct signaling pathways. Embo J, 20, 2497–2507.
Rios, C. D., Jordan, B. A., Gomes, I., and Devi, L. A. (2001) G protein coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther . 92, 71–87.
Rodriguez-Frade, J. M., Mellado, M., and Martinez-A, C. (2001) Chemokine receptor dimerization: two are better than one. Trends Immunol. 22, 612–617.
Rodriguez-Frade, J. M., Vila-Coro, A. J., de Ana, A. M., Albar, J. P., Martinez-A, C., and Mellado, M. (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. USA 96, 3628–3633.
Mellado, M., Rodriguez-Frade, J. M., Manes, S., and Martinez, A. C. (2001) Chemokine signaling and functional responses: the role of receptor dimerization and tk pathway activation. Annu. Rev. Immunol . 19, 397–421.
Vila-Coro, A. J., Mellado, M., Martin de Ana, A., Lucas, P., del Real, G., Martinez-A, C., and Rodriguez-Frade, J. M. (2000) HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97, 3388–3393.
Vila-Coro, A. J., Rodriguez-Frade, J. M., Martin De Ana, A., Moreno-Ortiz, M. C., Martinez-A, C., and Mellado, M. (1999) The chemokine SDF-1 alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J . 13, 1699–1710.
Cheng, Z. J. and Miller, L. J. (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem . 276, 48040–48047.
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., and Patel, Y. C. (2000) Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J. Biol. Chem . 275, 7862–7869.
Patel, R. C., Kumar, U., Lamb, D. C., et al. (2002) Ligand binding to somatostatin receptors induces receptors-specific oligomer formation in live cells. Proc. Natl. Acad. Sci. USA 99, 3294–3299.
Horvat, R. D., Roess, D. A., Nelson, S. E., Barisas, B. G., and Clay, C. M. (2001) Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors. Mol. Endocrinol 15, 695–703.
Margeta-Mitrovic, M., Jan, Y. N., and Jan, L. Y. (2001) Ligand-induced signal transduction within heterodimeric GABA(B) receptor. Proc. Natl. Acad. Sci. USA 98, 14643–14648.
Zhu, C. C., Cook, L. B., and Hinkle, P. M. (2002) Dimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulation. J. Biol. Chem . 277, 28228–28237.
Torvinen, M., Gines, S., Hillion, J., Latini, S., Canals, M., Ciruela, F., et al. (2002) Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons. Neuroscience 113, 709–719.
Kniazeff, J., Galvez, T., Labesse, G., and Pin, J. P. (2002) No ligand binding in the GB2 subunit of the GABA(B) receptor is required for activation and allosteric interaction between the subunits. J. Neurosci . 22, 7352–7361.
Issafras, H., Angers, S., Bulenger, S., et al. (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem . 277, 34666–34673.
Mercier, J. F., Salahpour, A., Angers, S., Breit, A., and Bouvier, M. (2002) Quantitative assessment of beta 1 and beta 2-adrenergic receptor homo and hetero-dimerization by bioluminescence resonance energy transfer. J. Biol. Chem . 277, 44925–44931.
Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., and Jockers, R. (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem 277, 21522–21528.
Kroeger, K. M., Hanyaloglu, A. C., Seeber, R. M., Miles, L. E., and Eidne, K. A. (2001) Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J. Biol. Chem . 276, 12736–12743.
Hebert, T. E., Moffett, S., Morello, J. P., Loisel, T. P., Bichet, D. G., Barret, C., and Bouvier, M. (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem . 271, 16384–16392.
Ng, G. Y., O’Dowd, B. F., Lee, S. R, Chung, H. T., Brann, M. R., Seeman, P., and George, S. R. (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Commun . 227, 200–204.
Romano, C., Yang, W. L., and O’Malley, K. L. (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem . 271, 28612–28616.
Cvejic, S. and Devi, L. A. (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J. Biol. Chem . 272, 26959–26964.
Bai, M., Trivedi, S., and Brown, E. M. (1998) Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Chem . 273, 23605–23610.
Zeng, F. Y. and Wess, J. (1999) Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem . 274, 19487–19497.
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., and Devi, L. A. (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20, RC 110.
Pfeiffer, M., Koch, T., Schroder, H., et al. (2001) Homo-and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem . 276, 14027–14036.
Jordan, B. A., Trapaidze, N., Gomes, I., Nivarthi, R., and Devi, L. A. (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogenactivated protein kinase activation. Proc. Natl. Acad. Sci. USA 98, 343–348.
Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA 97, 3684–3689.
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., and Milligan, G. (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem . 276, 14092–14099.
Overton, M. C. and Blumer, K. J. (2000) G protein-coupled receptors function as oligomers in vivo. Curr. Biol . 10, 341–344.
Cornea, A., Janovick, J. A., Maya-Nunez, G., and Conn, P. M. (2001) Gonadotropinreleasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J. Biol. Chem . 276, 2153–2158.
Babcock, G. J., Farzan, M., and Sodroski, J. (2002) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. Nov 13; [epub ahead of print].
Goldsmith, R K., Fan, G. E, Ray, K., Shiloach, J., McPhie, R, Rogers, K. V., and Spiegel, A. M. (1999) Expression, purification, and biochemical characterization of the aminoterminal extracellular domain of the human calcium receptor. J. Biol. Chem . 274, 11303–11309.
Pace, A. J., Gama, L., and Breitwieser, G. E. (1999) Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys–Ser mutations at Cysl01 and Cys236. J. Biol. Chem . 274, 11629–11634.
Kunishima, N., Shimada, Y., Tsuji, Y., et al. (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971–977.
AbdAlla, S., Zaki, E., Lother, H., and Quitterer, U. (1999) Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization. J. Biol. Chem . 274, 26079–26084.
Abe, J., Suzuki, H., Notoya, M., Yamamoto, T., and Hirose, S. (1999) Ig-hepta, a novel member of the G protein-coupled hepta-helical receptor (GPCR) family that has immunoglobulin-like repeats in a long N-terminal extracellular domain and defines a new subfamily of GPCRs. J. Biol. Chem . 274, 19957–19964.
Overton, M. C. and Blumer, K. J. (2002) The extracellular N-terminal domain and trans-membrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. J. Biol. Chem . 277, 41463–41472.
Fleming, K. G. and Engelman, D. M. (2001) Specificity in transmembrane helix-helix interactions can define a hierarchy of stability for sequence variants. Proc. Natl. Acad. Sci. USA 98, 14340–14344.
George, S. R., Lee, S. R, Varghese, G., Zeman, R. R., Seeman, P., Ng, G. Y., and O’Dowd, B. F. (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem . 273, 30244–30248.
Maggio, R., Vogel, Z., and Wess, J. (1993) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular “cross-talk” between G protein-linked receptors. Proc. Natl. Acad. Sci. USA 90, 3103–3107.
Hamdan, F. F., Ward, S. D., Siddiqui, N. A., Bloodworth, L. M., and Wess, J. (2002) Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor. Biochemistry 41, 7647–7658.
Hadac, E. M., Ji, Z., Pinon, D. I., Henne, R. M., Lybrand, T. P., and Miller, L. J. (1999) A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely. J. Med. Chem . 42, 2105–2111.
Lemmon, M. A., Flanagan, J. M., Treutlein, H. R., Zhang, J., and Engelman, D. M. (1992) Sequence specificity in the dimerization of transmembrane a-helices. Biochemistry 31, 12719–12725.
Ray, K. and Hauschild, B. C. (2000) Cys-140 is critical for metabotropic glutamate receptor-1 dimerization. J. Biol. Chem . 275, 34245–34251.
Lee, S. P., Xie, Z., Varghese, G., Nguyen, T., O’Dowd, B. F., and George, S. R. (2000) Oligomerization of dopamine and serotonin receptors. Neuropsychopharmacology 23, S32–40.
Zhang, Z., Sun, S., Quinn, S. J., Brown, E. M., and Bai, M. (2001) The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J. Biol. Chem . 276, 5316–5322.
Tsuji, Y., Shimada, Y., Takeshita, T., et al. (2000) Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J. Biol. Chem . 275, 28144–28151.
Romano, C., Miller, J. K., Hyrc, K., et al. (2001) Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. Mol. Pharmacol . 59, 46–53.
Schulz, A., Grosse, R., Schultz, G., Gudermann, T., and Schoneberg, T. (2000) structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors. J. Biol. Chem . 275, 2381–2389.
Gouldson, P. R. and Reynolds, C. A. (1997) Simulations on dimeric peptides: evidence for domain swapping in G protein-coupled receptors? Biochem. Soc. Trans . 25, 1066–1071.
Gouldson, P. R., Snell, C. R., and Reynolds, C. A. (1997) A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G protein-coupled receptors. J. Med. Chem . 40, 3871–3886.
Gouldson, P. R., Snell, C. R., Bywater, R. P., Higgs, C., and Reynolds, C. A. (1998) Domain swapping in G protein coupled receptor dimers. Prot. Eng . 11, 1181–1193.
Gouldson, P. R., Higgs, C., Smith, R. E., Dean, M. K., Gkoutos, G. V., and Reynolds, C. A. (2000) Dimerization and domain swapping in G protein-coupled receptors: a computational study. Neuropsychopharmacology 23, S60 - S77.
Monnot, C., Bihoreau, C., Conchon, S., Curnow, K. M., Corvol, P., and Clauser, E. (1996) Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem . 271, 1507–1513.
Davies, A., Gowen, B. E., Krebs, A. M., Schertler, G. F., and Saibil, H. R. (2001) Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. J. Mol. Biol . 314, 455–463.
Krebs, A., Villa, C., Edwards, P. C., and Schertler, G. F. (1998) Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. J. Mol. Biol . 282, 991–1003.
Schertler, G. F. and Hargrave, P. A. (1995) Projection structure of frog rhodopsin in two crystal forms. Proc. Natl. Acad. Sci. USA 92, 11578–11582.
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., and Palczewski, K. (2003) Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421, 127–128.
Jones, S. and Thornton, J. M. (1996) Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93, 13–20.
Norel, R., Petrey, D., Wolfson, H. J., and Nussinov, R. (1999) Examination of shape cornplementarity in docking of unbound proteins. Proteins 36, 307–317.
Lo Conte, L., Chothia, C., and Janin, J. (1999) The atomic structure of protein-protein recognition sites. J. Mol. Biol . 285, 2177–2198.
Gavin, A. C., Bosche, M., Krause, R., et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141–147.
Ho, Y., Gruhler, A., Heilbut, A., et al. (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180–183.
Zhu, H., Bilgin, M., Bangham, R., et al. (2001) Global analysis of protein activities using proteome chips. Science 293, 2101–2105.
Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245–246.
Valencia, A. and Pazos, F. (2002) Computational methods for the prediction of protein interactions. Curr. Opin. Struct. Biol . 12, 368–373.
Smith, G. R. and Sternberg, M. J. (2002) Prediction of protein-protein interactions by docking methods. Curr. Opin. Struct. Biol . 12, 28–35.
Dixon, J. S. (1997) Evaluation of the CASP2 docking section. Proteins Suppl. 1, 198–204.
Moller, S., Vilo, J., and Croning, M. D. (2001) Prediction of the coupling specificity of G protein coupled receptors to their G proteins. Bioinformatics 17, S174–181.
Goh, C. S. and Cohen, F. E. (2002) Co-evolutionary analysis reveals insights into protein-protein interactions. J. Mol. Biol . 324, 177–192.
Oliveira, L., Paiva, A. C., and Vriend, G. (2002) Correlated mutation analysis on very large sequence families. Chembiochem 3, 1010–1017.
Horn, F., van der Wenden, E. M., Oliveira, L., AP, I. J., and Vriend, G. (2000) Receptors coupling to G proteins: is there a signal behind the sequence? Proteins 41, 448–459.
Oliveira, L., Paiva, A. C., and Vriend, G. (1999) A low resolution model for the interaction of G proteins with G protein-coupled receptors. Prot. Eng . 12, 1087–1095.
Lichtarge, O., Sowa, M. E., and Philippi, A. (2002) Evolutionary traces of functional surfaces along G protein signaling pathway. Methods Enzymol. 344, 536–556.
Lichtarge, O., Bourne, H. R., and Cohen, F. E. (1996) Evolutionarily conserved Galphabetagamma binding surfaces support a model of the G protein-receptor complex. Proc. Natl. Acad. Sci. USA 93, 7507–7511.
Dean, M. K., Higgs, C., Smith, R. E., et al. (2001) Dimerization of G protein-coupled receptors. J. Med. Chem . 44, 4595–4614.
Gobel, U., Sander, C., Schneider, R., and Valencia, A. (1994) Correlated mutations and residue contacts in proteins. Proteins 18, 309–317.
Olmea, O. and Valencia, A. (1997) Improving contact predictions by the combination of correlated mutations and other sources of sequence information. Fold Des. 2, S25–32.
Pazos, F., Olmea, O., and Valencia, A. (1997) A graphical interface for correlated mutations and other protein structure prediction methods. Comput. Appl. Biosci . 13, 319–321.
Pazos, F., Helmer-Citterich, M., Ausiello, G., and Valencia, A. (1997) Correlated mutations contain information about protein-protein interaction. J. Mol. Biol . 271, 511–523.
Pazos, F. and Valencia, A. (2002) In silico two-hybrid system for the selection of physically interacting protein pairs. Proteins 47, 219–227.
Lichtarge, O., Bourne, H. R., and Cohen, F. E. (1996) An evolutionary trace method defines binding surfaces common to protein families. J. Mol. Biol . 257, 342–358.
Madabushi, S., Yao, H., Marsh, M., Kristensen, D. M., Philippi, A., Sowa, M. E., and Lichtarge, O. (2002) Structural clusters of evolutionary trace residues are statistically significant and common in proteins. J. Mol. Biol . 316, 139–154.
Lichtarge, O. and Sowa, M. E. (2002) Evolutionary predictions of binding surfaces and interactions. Curr. Opin. Struct. Biol . 12, 21–27.
Gouldson, P. R., Dean, M. K., Snell, C. R., Bywater, R. P., Gkoutos, G., and Reynolds, C. A. (2001) Lipid-facing correlated mutations and dimerization in G protein coupled receptors. Prot. Eng . 14, 759–767.
Gkoutos, G. V., Higgs, C., Bywater, R. P., Gouldson, P. R., and Reynolds, C. A. (1999) Evidence for dimerization in the (32-adrenergic receptor from the evolutionary trace method. Intl. J. Quantum. Chem. Biophys. Q . 74, 371–379.
Filizola, M., Guo, W., Javitch, J. A., and Weinstein, H. (2003) Dimerization in G protein coupled receptors: Correlation analysis and electron density maps of rhodopsin from different species suggest subtype-specific interfaces. Biophys. J. 84(2), 1309 Pos Part 2.
Filizola, M., Olmea, O., and Weinstein, H. (2002) Prediction of heterodimerization interfaces of G protein coupled receptors with a new subtractive correlated mutation method. Prot. Eng . 15, 881–885.
Filizola, M., Olmea, O., and Weinstein, H. (2002) Using correlated mutation analysis to predict the heterodimerization interface of GPCRs. Biophys. J. 82, 2307. (Part 2302 Jan 2002.)
Filizola, M. and Weinstein, H. (2002) Structural models for dimerization of G protein coupled receptors: the opioid receptor homodimers. Biopolymers (Peptide Sci.) 66, 317–325.
Kuipers, W., Oliveira, L., Vriend, G., and Ijzerman, A. P. (1997) Identification of class-determining residues in G protein-coupled receptors by sequence analysis. Recept. Channels 5, 159–174.
Singer, M. S., Oliveira, L., Vriend, G., and Shepherd, G. M. (1995) Potential ligand-binding residues in rat olfactory receptors identified by correlated mutation analysis. Recept. Channels 3, 89–95.
Geva, A., Lassere, T. B., Lichtarge, O., Pollitt, S. K., and Baranski, T. J. (2000) Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function. J. Biol. Chem . 275, 35393–35401.
Baranski, T. J., Herzmark, P., Lichtarge, O., et al. (1999) C5a receptor activation. Genetic identification of critical residues in four transmembrane helices. J. Biol. Chem . 274, 15757–15765.
Jordan, B. A., Cvejic, S., and Devi, L. A. (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23, S5–S18.
Devi, L. A. (2000) G protein-coupled receptor dimers in the lime light. Trends Pharmacol. Sci . 21, 324–326.
Ramsay, D., Kellett, E., McVey, M., Rees, S., and Milligan, G. (2002) Homo-and heterooligomeric interactions between G protein-coupled receptors in living cells monitored by two variants of bioluminescene resonance energy transfer. Biochem. J . 365, 429–440.
Suzuki, S., Chuang, L. F., Yau, P., Doi, R. H., and Chuang, R. Y. (2002) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp. Cell. Res . 280, 192–200.
Hoffmann, A., Levchenko, A., Scott, M. L., and Baltimore, D. (2002) The IkappaB-NFKappaB signaling module: temporal control and selective gene activation. Science 298, 1241–1245.
Bhalla, U. S., Ram, P. T., and Iyengar, R. (2002) MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297, 1018–1023.
Neves, S. R. and Iyengar, R. (2002) Modeling of signaling networks. Bioessays 24, 1110–1117.
Neves, S. R., Ram, P. T., and Iyengar, R. (2002) G protein pathways. Science 296, 1636–1639.
Ciruela, F., Casado, V., Mallol, J., Canela, E. I., Lluis, C., and Franco, R. (1995) Immunological identification of Al adenosine receptors in brain cortex. J. Neurosci. Res . 42, 818–828.
Cirula, F., Escriche, M., Burgueno, J., et al. (2001) Metabotropic glutamate lalpha and adenosine Al receptors assemble into functionally interacting complexes. J. Biol. Chem . 276, 18345–18351.
Yoshioka, K., Saitoh, O., and Nakata, H. (2001) Heteromeric association creates a P2Ylike adenosine receptor. Proc. Natl. Acad. Sci. USA 98, 7617–7622.
Hillion, J., Canals, M., Torvinen, M., et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem . 277, 18091–18097.
AbdAlla, S., Lother, H., Abdel-tawab, A. M., and Quitterer, U. (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem . 276, 39721–39726.
AbdAlla, S., Lother, H., el Massiery, A., and Quitterer, U. (2001) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med . 7, 1003–1009.
Xu, J., He, J., Castleberry, A., Balasubramanian, S., Lau, A. G., and Hall, R. A. (2003) Heterodimerization of alpha-2A- and beta-1-adrenergic receptors. J. Biol. Chem . 278, 10770–10777.
Lavoie, C., Mercier, J. F., Salahpour, A., Umapathy, D., Breit, A., Villeneuve, L. R., et al. (2002) Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J. Biol. Chem . 277, 35402–35410.
Mukhopadhyay, S., McIntosh, H. H., Houston, D. B., and Howlett, A. C. (2000) The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol . 57, 162–170.
Ng, G. Y., Mouillac, B., George, S. R., Caron, M., Dennis, M., Bouvier, M., and O’Dowd, B. F. (1994) Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur. J. Pharmacol . 267, 7–19.
Nimchinsky, E. A., Hof, P. R., Janssen, W. G., Morrison, J. H., and Schmauss, C. (1997) Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J. Biol. Chem . 272, 29229–29237.
Scarselli, M., Novi, F., Schallmach, E., et al. (2001) D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem . 276, 30308–30314.
Fukushima, Y., Asano, T., Satioh, T., et al. (1997) Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells. FEBS Lett. 409, 283–286.
Nguyen, T., Shapiro, D. A., George, S. R., et al. (2001) Discovery of a novel member of the histamine receptor family. Mol. Pharmacol . 59, 427–433.
Ng, G. Y., George, S. R., Zastawny, R. L., Caron, M., Bouvier, M., Dennis, M., and O’Dowd, B. F. (1993) Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 32, 11727–11733.
Xie, Z., Lee, S. P., O’Dowd, B. E, and George, S. R. (1999) Serotonin 5-HT1B and 5HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett. 456, 63–67.
Indrapichate, K., Meehan, D., Lane, T. A., et al. (1992) Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies. Biol. Reprod . 46, 265–278.
Roess, D. A., Horvat, R. D., Munnelly, H., and Barisas, B. G. (2000) Luteinizing hormone receptors are self-associated in the plasma membrane. Endocrinology 141, 4518–4523.
Maggio, R., Barbier, P., Colelli, A., Salvadori, F., Demontis, G., and Corsini, G. U. (1999) G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J. Pharmacol. Exp. Ther . 291, 251–257.
Sawyer, G. W. and Ehlert, F. J. (1999) Muscarinic M3 receptor inactivation reveals a pertussis toxin-sensitive contractile response in the guinea pig colon: evidence for M2/M3 receptor interactions. J. Pharmacol. Exp. Ther . 289, 464–476.
Dinger, M. C., Bader, J. E., Kobor, A. D., Kretzschmar, A. K., and Beck-Sickinger, A. G. (2003) Homodimerization of neuropeptide Y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem . 10, 10.
Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V., and Schulz, S. (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J. Biol. Chem . 277, 19762–19772.
Hanyaloglu, A. C., Seeber, R. M., Kohout, T. A., Lefkowitz, R. J., and Eidne, K. A. (2002) Homo and hetero-oligomerization of thyrotropin releasing hormone (TRH) receptor subtypes: differential regulation of -arrestins 1 and 2. J. Biol. Chem . 277, 50422–50430.
Cornea, A. and Michael Conn, P. (2002) Measurement of changes in fluorescence resonance energy transfer between gonadotropin-releasing hormone receptors in response to agonists. Methods 27, 333.
Ng, G. Y., Clark, J., Coulombe, N., et al. (1999) Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J. Biol. Chem . 274, 7607–7610.
Nelson, G., Chandrashekar, J., Hoon, M. A., Feng, L., Zhao, G., Ryba, N. J., and Zuker, C. S. (2002) An amino-acid taste receptor. Nature 416, 199–202.
Nelson, G., Hoon, M. A., Chandrashekar, J., Zhang, Y., Ryba, N. J., and Zuker, C. S. (2001) Mammalian sweet taste receptors. Cell 106, 381–390.
Yesilaltay, A. and Jenness, D. D. (2000) Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. Mol. Biol. Cell . 11, 2873–2884.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Filizola, M., Visiers, I., Skrabanek, L., Campagne, F., Weinstein, H. (2004). Functional Mechanisms of G Protein-Coupled Receptors in a Structural Context. In: Schousboe, A., Bräuner-Osborne, H. (eds) Molecular Neuropharmacology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-672-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-672-0_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-384-8
Online ISBN: 978-1-59259-672-0
eBook Packages: Springer Book Archive